Total Payments
$8,691
2024 Payments
$1,524
Companies
42
Transactions
350
Medicare Patients
2,741
Medicare Billing
$510,458
Payment Breakdown by Category
Food & Beverage$8,630 (99.3%)
Education$60.80 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,630 | 348 | 99.3% |
| Education | $60.80 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,000 | 42 | $0 (2024) |
| Novo Nordisk Inc | $979.91 | 57 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $924.66 | 28 | $0 (2024) |
| GlaxoSmithKline, LLC. | $646.15 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $545.43 | 14 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $426.66 | 17 | $0 (2023) |
| Lilly USA, LLC | $366.76 | 14 | $0 (2024) |
| PFIZER INC. | $364.40 | 15 | $0 (2024) |
| Allergan, Inc. | $363.46 | 9 | $0 (2020) |
| Avanir Pharmaceuticals, Inc. | $341.95 | 17 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,524 | 65 | ABBVIE INC. ($329.85) |
| 2023 | $1,801 | 66 | Novo Nordisk Inc ($292.63) |
| 2022 | $1,487 | 73 | Vanda Pharmaceuticals Inc. ($264.84) |
| 2021 | $1,332 | 57 | AstraZeneca Pharmaceuticals LP ($308.33) |
| 2020 | $461.79 | 29 | Vanda Pharmaceuticals Inc. ($66.66) |
| 2019 | $1,339 | 39 | PFIZER INC. ($252.59) |
| 2018 | $204.03 | 7 | Allergan Inc. ($122.53) |
| 2017 | $543.38 | 14 | Boehringer Ingelheim Pharmaceuticals, Inc. ($131.47) |
All Payment Transactions
350 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 11/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $7.09 | General |
| Category: Obesity | ||||||
| 11/22/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.58 | General |
| Category: Neuroscience | ||||||
| 11/06/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: Oncology | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: RESPIRATORY | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $121.41 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Diabetes | ||||||
| 10/05/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: PSYCHIATRY | ||||||
| 09/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.20 | General |
| Category: NEUROSCIENCE | ||||||
| 09/18/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Respiratory | ||||||
| 09/14/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 09/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: Diabetes Care | ||||||
| 09/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: PAIN | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: PSYCHIATRY | ||||||
| 08/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: RESPIRATORY | ||||||
| 08/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.87 | General |
| Category: Obesity | ||||||
| 08/01/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 07/31/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Diabetes | ||||||
| 07/25/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Neuroscience | ||||||
| 07/12/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.87 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.41 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 534 | 1,808 | $206,301 | $110,029 |
| 2022 | 11 | 556 | 1,802 | $199,658 | $115,437 |
| 2021 | 11 | 652 | 2,203 | $228,690 | $127,378 |
| 2020 | 15 | 999 | 3,175 | $301,480 | $157,615 |
Total Patients
2,741
Total Services
8,988
Medicare Billing
$510,458
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 600 | $81,000 | $52,406 | 64.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 94 | 618 | $77,260 | $34,184 | 44.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 56 | 56 | $8,705 | $6,861 | 78.8% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 78 | 236 | $20,075 | $6,608 | 32.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 112 | $10,080 | $6,318 | 62.7% |
| 99342 | Residence visit for new patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 21 | 21 | $4,200 | $1,138 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 11 | 11 | $1,485 | $788.68 | 53.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 28 | 61 | $1,525 | $588.02 | 38.6% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 15 | 16 | $560.00 | $470.55 | 84.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 18 | 19 | $475.00 | $465.50 | 98.0% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2023 | 15 | 30 | $376.00 | $170.88 | 45.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 28 | $560.00 | $29.23 | 5.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 132 | 562 | $75,870 | $49,458 | 65.2% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 86 | 360 | $48,600 | $24,386 | 50.2% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 86 | 436 | $39,240 | $17,971 | 45.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 84 | 223 | $20,070 | $12,684 | 63.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 63 | 63 | $9,765 | $7,887 | 80.8% |
| 99325 | New patient custodial care facility, group care, or assisted living visit, typically 30 minutes | Office | 2022 | 25 | 25 | $3,125 | $1,519 | 48.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 21 | 22 | $550.00 | $540.50 | 98.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 23 | 49 | $1,225 | $500.23 | 40.8% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2022 | 11 | 11 | $385.00 | $329.67 | 85.6% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 14 | 27 | $348.00 | $131.24 | 37.7% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 11 | 24 | $480.00 | $30.87 | 6.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 150 | 590 | $79,650 | $51,973 | 65.3% |
| 99334 | Established patient assisted living visit, typically 15 minutes | Office | 2021 | 112 | 726 | $65,340 | $29,199 | 44.7% |
About Dr. Harold Roth, D.O
Dr. Harold Roth, D.O is a General Practice healthcare provider based in Lansing, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2005. The National Provider Identifier (NPI) number assigned to this provider is 1023005659.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Harold Roth, D.O has received a total of $8,691 in payments from pharmaceutical and medical device companies, with $1,524 received in 2024. These payments were reported across 350 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,630).
As a Medicare-enrolled provider, Roth has provided services to 2,741 Medicare beneficiaries, totaling 8,988 services with total Medicare billing of $510,458. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty General Practice
- Location Lansing, MI
- Active Since 09/29/2005
- Last Updated 01/01/2018
- Taxonomy Code 208D00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1023005659
Products in Payments
- REXULTI (Drug) $605.62
- VRAYLAR (Drug) $454.85
- QULIPTA (Drug) $453.11
- TRELEGY ELLIPTA (Drug) $414.83
- HETLIOZ (Drug) $394.99
- FARXIGA (Drug) $376.25
- NUEDEXTA (Drug) $324.92
- Ozempic (Drug) $303.62
- UBRELVY (Drug) $282.85
- NURTEC ODT (Drug) $265.14
- AIRSUPRA (Drug) $222.16
- CAPLYTA (Drug) $217.09
- Wegovy (Drug) $208.79
- JARDIANCE (Drug) $201.10
- BREZTRI (Drug) $201.07
- VOQUEZNA (Drug) $179.40
- QUVIVIQ (Drug) $163.41
- Rybelsus (Drug) $153.67
- BELSOMRA (Drug) $152.67
- TRULICITY (Drug) $141.26
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
General Practice Doctors in Lansing
Dr. Paul Rashid, D.m.d, D.M.D
General Practice — Payments: $41,177
General Practice $41,177
Brian Schaefer, Dds, DDS
General Practice — Payments: $22,091
General Practice $22,091
Dr. Jason Baker, D.d.s, D.D.S
General Practice — Payments: $4,055
General Practice $4,055
Dr. Shaun Williams, D.d.s, D.D.S
General Practice — Payments: $2,740
General Practice $2,740
Dr. Daniel Zick, D.d.s, D.D.S
General Practice — Payments: $2,163
General Practice $2,163
Dr. Nathan Jandernoa, Dds, DDS
General Practice — Payments: $1,747
General Practice $1,747